Journal Article

The progress and future of the treatment of Candida albicans infections based on nanotechnology

Xiao, Yuyang, Meng, Lingtong, Huang, He, Wu, Yue, Ding, Liang, Gao, Yang, Yang, Jingpeng, Cao, Qinyan, Li, Yanan

2024

Overview

Systemic infection with Candida albicans poses a significant risk for people with weakened immune systems and carries a mortality rate of up to 60%. However, current therapeutic options have several limitations, including increasing drug tolerance, notable off-target effects, and severe adverse reactions. Over the past four decades, the progress in developing drugs to treat Candida albicans infections has been sluggish. This comprehensive review addresses the limitations of existing drugs and summarizes the efforts made toward redesigning and innovating existing or novel drugs through nanotechnology. The discussion explores the potential applications of nanomedicine in Candida albicans infections from four perspectives: nano-preparations for anti-biofilm therapy, innovative formulations of “old drugs” targeting the cell membrane and cell wall, reverse drug resistance therapy targeting subcellular organelles, and virulence deprivation therapy leveraging the unique polymorphism of Candida albicans . These therapeutic approaches are promising to address the above challenges and enhance the efficiency of drug development for Candida albicans infections. By harnessing nano-preparation technology to transform existing and preclinical drugs, novel therapeutic targets will be uncovered, providing effective solutions and broader horizons to improve patient survival rates. Graphical abstracts

• Publisher: BioMed Central,BioMed Central Ltd,BMC
• Subject: Analysis / Animals / Antifungal Agents - pharmacology / Antifungal Agents - therapeutic use / Biofilms - drug effects / Biotechnology / Cancer / Candida albicans / Candida albicans - drug effects / Candidiasis / Candidiasis - drug therapy / Care and treatment / Chemistry / Chemistry and Materials Science / Chemotherapy / Diagnosis / Disease susceptibility / Drug Delivery Systems - methods / Drug resistance / Drug Resistance, Fungal - drug effects / Humans / Hyphae / Molecular Medicine / Nanomedicine / Nanomedicine - methods / Nanoparticles - chemistry / Nanoparticles - therapeutic use / Nanotechnology / Nanotechnology - methods / Patient outcomes / Prevention / Review / Subcellular organelles